Chapter 6: Diseases of the Immune System

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Grab your coffee or your energy drink or, you know, whatever keeps you lucid right now because today we are tackling an absolute beast of a topic.

We really are.

It is arguably the most complex system in the human body.

Yeah, the most complex, the most fascinating,

and let's be honest, sometimes the most terrifying.

Absolutely.

Today we are doing a complete teardown of the immune system.

But we aren't just talking about, you know, how it fights off the flu or a common cold.

We're looking at the dark side of things.

Right.

What happens when this incredible defense force just goes rogue?

Exactly.

We're calling this the Double -Edged Sword Deep Dive because on one hand, without an immune system, you basically don't survive a paper cut.

You really don't.

But on the other hand, as we're going to see today, if it turns against you or if it just decides to take a personal day and fail, the results are catastrophic.

That is the perfect way to frame it.

The immune system is capable of causing fatal disease just as easily as it prevents it.

It's a system entirely defined by balance.

So here's our mission for today.

We have a massive stack of notes, specifically chapter six, from the absolute Bible of Pathology, Robbins, Cotran, and Kumar Pathologic Basis of Disease.

The 11th edition, yeah.

Right.

And our goal is to create the ultimate last minute lecture for you.

So this is for the medical students sweating right before an exam or the biology major trying to connect all these crazy dots or just the intensely curious listener who wants to master the pathology of the immune system without waiting through 40 pages of dense text right this second.

Yeah.

We're going to walk through the chapter exactly as it's laid out in the text, concept by concept.

We'll start with the normal immune response, which is the foundation.

Got to have the foundation.

Exactly.

Then we move into hypersensitivity, which is when the system just overreacts.

Then autoimmunity, where we lose tolerance to our own tissues.

The civil war.

Right.

And then we'll touch on transplant rejection, immunodeficiency, and finally, a condition that often gets tapped on but is incredibly important, which is amyloidosis.

It sounds like a marathon, but we are going to sprint through it.

Let's start right at the beginning.

The foundation.

In Robbins, they divide the immune response into two arms.

Can you set the stage for us?

Sure.

So you have innate immunity and adaptive immunity.

Think of innate immunity as your first responders.

The text also calls this natural or native immunity.

Because it's just always there.

It is always poised to react immediately.

It doesn't need to learn anything.

It doesn't need to be introduced to a bug.

It knows what to do from birth.

So these are the guys already on the scene.

If I get a splinter, they are already waiting.

Exactly.

And it starts with the physical barriers, your epithelial barriers, which is literally your skin and your mucosal linings in your gut and respiratory tract.

Just keeping things out.

Right.

But if a bug gets past that, it meets the cellular defense.

These are phagocytes like neutrophils and macrophages.

You also have natural killer cells and plasma proteins, specifically the complement system.

I want to pause on the recognition part for a second because I think this is where people, or at least I, get confused.

How does a macrophage know that a bacteria is a bad guy without ever having met it before?

That is the crucial question, isn't it?

They use a pattern recognition system.

The text specifically highlights toll -like receptors, or TLRs.

Toll -like receptors?

Yeah.

These are evolutionary ancient sensors on the immune cells.

They don't look for a highly specific strain of E.

coli.

They look for what we call conserved molecular patterns.

Okay, like a general barcode that all bad guys happen to share.

Precisely.

Things like lipopolysaccharide or endotoxin, which is found on a bacterial cell wall.

Humans simply don't make that molecule.

So it's a dead giveaway.

Exactly.

So if a macrophage sees that using its toll -like receptor, it knows immediately this is not self.

Attack it.

And what happens once that alarm is triggered?

Because it's not just about eating the bug, right?

There's a whole chemical signal that goes out.

Right.

And this is a major molecular mechanism we need to understand.

When the TLR is activated, it triggers a complex signaling cascade inside the immune cell, specifically involving a pathway called NFKB.

NFKB.

That sounds like a secret code.

It's a transcription factor.

So it moves into the nucleus of the cell and literally turns on the genes for war.

It stimulates the production of cytokines, things like tumor necrosis factor or TNF, and interleukin -1.

IL -1.

Yes, IL -1.

These are the chemical sirens.

They cause fever and they recruit other immune cells out of the blood and into the tissue to join the fight.

Okay.

So that's the cellular side of innate immunity, neutrophils and macrophages using TLRs.

But you also mentioned plasma proteins, the complement system.

Now this always trips students up.

It is notoriously complex, but think of it as a domino effect in your blood.

You have these proteins floating around, mostly made by the liver, and they're totally inactive.

Just wait.

Right.

But when they get triggered, either by an antibody or by a microbe directly, they start cleaving each other.

They cut each other into active pieces.

C3 gets split into C3A and C3B, for instance.

And what is the actual end game of that cascade?

What does it do to the bacteria?

The ultimate end game is the MSC attack.

The MSC attack.

The membrane attack complex.

These complement proteins actually assemble themselves into a microscopic tube, punch a physical hole right through the bacterial cell membrane, and the bacteria just explodes.

Water rushes in and it bursts.

That is so metal.

It basically drills a hole in the enemy ship.

Exactly.

It's highly effective.

So that is innate immunity in a nutshell.

Fast, non -specific, pattern -based.

Got it.

Then we have the second arm, the adaptive immunity.

I always think of these guys as the special forces.

That's a great analogy because they are highly specific and highly trained.

Adaptive or acquired immunity consists of your lymphocytes, your T cells and B cells.

And their superpower is memory, right?

The key feature here is specificity and memory, yes.

The first time they see a bug, they have to learn it.

That takes days.

But the second time, they remember.

The response is massive, fast, and completely targeted.

Okay, let's meet the cast of characters here.

Because Robbins lays this out very clearly.

If you're looking at a slide or reading a case study, who are the key players you really need to In the adaptive world, you have T lymphocytes.

These develop in the thymus.

They are the only cells in the body with specific antigen receptors.

And you have two main flavors to remember.

CD4 positive helper T cells and CD8 positive cytotoxic T cells.

I've heard them called the generals and the assassins.

That is spot on.

The CD4 helper cells are the generals.

They don't usually go down into the trenches and kill things themselves.

They sit back and secrete cytokines that direct everyone else.

Giving orders.

They tell the macrophages to eat faster and they tell the B cells to make antibodies.

They coordinate the whole specialized attack.

And the CD8s?

The CD8 cytotoxic cells are the assassins.

They directly kill infected cells.

If one of your cells has a virus hiding inside it, the CD8 cell finds it, binds to it, and induces apoptosis.

It forces the infected cell to commit suicide.

Wow.

Okay, then we have the B lymphocytes.

Thrive from the bone marrow, that's easy to remember.

B for bone marrow, T for thymus.

Their entire job is to produce antibodies.

They are the mediators of humoral immunity.

And we can't forget the scouts because none of this works if the generals don't know there's an invasion.

Exactly.

The dendritic cells, these are absolutely crucial.

You find them hanging out right under epithelial surfaces like your skin.

Under the microscope, they look almost like amoebas with these long starry arms.

Reaching out to grab things.

Right.

They capture antigens in the tissues, say from that splinter you got, and they physically detach and travel through the lymphatic vessels to the lymph nodes to present those antigens to the T cells.

Without dendritic cells, the P cells would have no idea there's a war going on.

There's actually a newer group mentioned in the Robbins text too, right?

The innate lymphoid cells.

Yes.

ILCs.

They are really interesting.

They are tissue resident cells.

Morphologically, they look exactly like lymphocytes, but they completely lack T cell receptors.

So they can't recognize specific antigens.

Right.

But they secrete cytokines, just like T cells do when they're triggered by danger signals.

We classify them into groups 1, 2, and 3, which directly mirrors the T helper cell subsets.

They act like a bridge between the rapid innate response and the targeted adaptive response.

Okay.

So we have our players.

Now, Robbins gives us a very specific visual of where this happens.

Figure 6 .8 describes the morphology of a lymph node.

Can you paint a picture for us?

If I'm shrinking down and walking into a lymph node, what am I actually seeing?

Imagine the lymph node is a highly organized, heavily fortified command center.

It's bean -shaped.

On the very outside edge, right under the capsule, you have the cortex.

This is where the follicles are.

And follicles mean B cells.

The follicles are the B cell zone.

If the B cells in a follicle get activated by an infection, you'll see pale centers forming in the middle of them under the microscope.

Those are called germinal centers.

That's where B cells are aggressively multiplying and refining their antibodies.

So outer layer cortex equals B cells.

Move inward for me.

As you move inward to the paracortex, you are in the T cell zone.

This architecture is very distinct.

And then deep inside the node is the medulla, where plasma cells hang out and dump antibodies into the outflow.

The traffic flow is critical here too, right?

Antigen and dendritic cells are brought in via afferent lymphatics, which pierce the outer capsule.

They percolate through the subcapsular sinus down through these zones,

essentially being heavily inspected by the B and T cells to see if anyone recognizes the invader.

It's basically a highly efficient security checkpoint.

Exactly.

And the ID card being checked at this checkpoint is the MHC molecule, the major histocompatibility complex.

This is the body's peptide display system.

Let's unpack MHC because this concept is the root of so much pathology that we're going to talk about later on.

What is an MHC molecule actually doing?

Okay.

Every single nucleated cell in your body has these MHC molecules on the surface.

Think of them like little biochemical hands holding up a serving tray.

Okay, a tray.

And on that tray, they constantly display snippets of proteins called peptides from the inside of the cell.

They're showing the immune system what they're building in their factory.

So if the cell is healthy and normal, it's just holding up self -peptides, normal human proteins.

Right.

And the roaming T cells walk by, check the tray, see the self -peptide and say, cool, you're one of us, nothing to see here.

Could have a virus infects that cell.

Exactly.

The cell gets hijacked, starts processing and building viral proteins.

Now the MHC molecule grabs a piece of that virus and holds it up on the tray.

And the T cell sees that.

And attacks instantly.

Now you need to know the two classes.

MHC class high is on all nucleated cells, every single one.

And that tray talks specifically to the CD8 assassins.

Because any cell can get a virus.

Right.

But MHC class two is special.

It is only found on professional antigen presenting cells like our dendritic cells and macrophages.

And that tray talks specifically to the CD4 generals to coordinate the broader war.

Okay.

So normally this whole elegant system works perfectly.

The T cells ignore self, they attack non -self.

Should being the operative word there.

Because now we are moving into section two of our roadmap, which is hypersensitivity.

This is when the system stops ignoring things it should ignore or just reacts way, way too hard.

Right.

The definition of hypersensitivity is an injurious immune reaction.

And we have to be clear.

It's not just allergies.

It is any immune mediated tissue injury.

And Robbins breaks these down into four distinct types.

If you are a medical student listening to this, you simply must memorize these four types and their exact mechanisms.

They will show up on your exams.

Unquestionably.

Let's untack them sequentially.

Type I.

This is what most people actually think of when they hear the word allergy.

Right.

So type I is immediate hypersensitivity.

Who are the key players here?

The key players are TH2 cells, IgE antibodies, and mast cells.

Walk us through the mechanism.

Say I breathe in some ragweed pollen.

What happens?

The very first time you encounter it, you don't actually get an allergic reaction.

You get sensitized.

That's a key pathology concept.

The antigen presenting cell grabs the pollen in your mucosa, travels to the lymph node, and shows it to a naive CD4 T cell.

But in an allergic person, something goes wrong here.

Right.

In a normal person, the T cell might just ignore it.

But in an allergic person, due to genetic susceptibility, that T cell decides to differentiate into a TH2 cell.

Why TH2 specifically?

Because TH2 cells secrete interleukin 4, or IL -4.

IL -4 is the specific cytokine that goes over to the B cells and tells them, hey, don't make standard IgM or IgG antibodies.

I need you to switch classes.

Make IgE.

Class switching to IgE.

So now we have these highly specific IgE antibodies floating around against ragweed.

And that IgE doesn't just float in the blood for long.

It strongly binds to FTOs receptors on the surface of mast cells, which are hanging out in your tissues.

So now your mast cells are primed.

They are literally coated in IgE.

They are like loaded landmines waiting for a trigger.

And then spring rolls around next year, and I breathe in the pollen again.

Boom.

The ragweed antigen enters the tissue and binds to the IgE on the mast cell.

But it doesn't just touch one IgE molecule, it cross -links them.

It bridges two adjacent IgE molecules together.

And that physical bridge is the trigger.

Yes.

That sends an immediate signal into the mast cell to degranulate.

It literally explodes its granules into the tissue, releasing preformed mediators.

The big one being histamine.

Yes.

Histamine is the primary early mediator.

Histamine causes rapid vasodilation, which causes redness.

And it makes the blood vessels leaky, which causes swelling or edema.

That's the classic wheel and flare reaction on the skin.

But here is where it gets interesting clinically.

Because sometimes you take an antihistamine, you feel better, but then hours later you feel terrible again.

That is the late phase reaction.

After the mast cell dumps its preformed histamine, it starts actively synthesizing new lipid mediators from its cell membrane,

specifically prostaglandins and leukotrenes.

Leukotrenes are the bad ones, right?

They are incredibly potent.

They are thousands of times more powerful than histamine at causing bronchospasm and mucus production.

This is exactly what causes the severe asthma attack hours after the initial exposure.

So type, I can be local, like hay fever or hives, but I can also be systemic?

Systemic anaphylaxis is the extreme, life -threatening form of type 1.

If the antigen gets into the bloodstream, say from a bee sting or a peanut allergy, mast cells all over the body degranulate at once.

That sounds like a disaster.

Widespread vasodilation causes your blood pressure to completely bottom out.

That's anaphylactic shock.

And simultaneously, massive bronchoconstriction completely closes your airway.

It is a dire medical emergency requiring immediate epinephrine.

Okay, so that's type 1.

Moving to type 2, this is antibody -mediated hypersensitivity.

How is this fundamentally different from type 1?

In type Y, the antibody, the IgE, is attached to a mast cell waiting for an antigen to flow by.

In type 2, the antibody, which is usually IgG or IgM, binds directly to a fixed antigen that is naturally attached to a cell or tissue in your body.

So think of an antibody latching onto a red blood cell or onto the basement membrane of your kidney.

Exactly.

It targets a specific tissue.

And once it latches on, Robbins lists three distinct ways it causes destruction or disease.

What's the first outcome?

First is opsonization and phagocytosis.

The antibody basically acts like a giant eat -me sign.

We call that an opsonin.

When the antibody coats a red blood cell, the macrophages in your spleen see that tagged cell and just devour it.

That's the mechanism for autoimmune hemolytic anemia.

Spot on.

The red cells are destroyed because they were tagged.

Outcome two is inflammation.

When antibodies bind to a tissue like the kidney basement membrane, they activate the complement system we talked about earlier.

The cascade.

Right.

And those complement byproducts like C5A recruit thousands of angry neutrophils to the tissue.

The neutrophils arrive.

They can't eat the basement membrane because it's too big.

So they just release all their digestive enzymes and reactive oxygen species right there, heavily damaging the tissue.

Frustrated phagocytosis.

A classic example here is good pasture syndrome, right?

Yes.

Good pasture.

Antibodies directly attack the basement membrane in the lungs and the kidneys.

The resulting inflammation means you cough up blood and you pee blood.

And the third outcome for type two is fascinating because it doesn't actually destroy the cell.

It just sort of hacks it.

Right.

It's called cellular dysfunction.

The antibody binds to a cellular receptor and completely messes with its function without killing the cell.

Give us an example.

Take Graves' disease.

The antibody binds to the TSH receptor on the thyroid gland.

But instead of destroying the gland,

the antibody structurally mimics TSH and stimulates the receptor.

It essentially tapes the switch in the ion position.

So the thyroid thinks the brain is constantly telling it to work, but it's actually the rogue antibody doing it.

Exactly.

So the patient gets severe hyperthyroidism.

Conversely, in mycidia gravis, the antibody binds to the acetylcholine receptor on the muscle M -plate and blocks it.

It turns the switch OFF.

No nerve signal gets through the muscle.

So you get profound muscle weakness, no tissue destruction, just major, major dysfunction.

That is a crucial pathology distinction for the boards.

Type two is antibodies attacking specific fixed cells or tissues.

Now type three is also antibody mediated, but it's more of a plumbing problem.

That's a great visual.

Type three is immune complex mediated hypersensitivity.

Yeah.

The key difference here is that the antigen and the antibody link up while they are freely circulating in the blood.

They form these physical clumps called immune complexes.

And these clumps just travel around the circulatory system.

They travel until they get stuck.

And they usually get stuck in areas where blood is filtered at high pressure.

So the glomeruli in the kidneys, the synovium in the joints, or the small blood vessels in the skin.

And when they get wedged in there.

Once they deposit in the vessel wall, they activate complement and trigger massive neutrophil driven inflammation, just like type two.

But the target wasn't specific.

They were just instant bystander tissues where the garbage happened to get dumped.

The text mentions a very specific microscopic buzzword for the morphology here.

If I'm looking at a pathology slide of a vessel wall in a type three reaction,

what do I see?

You see fibrinoid necrosis.

That is a must know term.

Because of the intense inflammation and necrosis, plasma proteins and fibrin leak into the vessel wall.

Under the microscope, you see this smudgy, intensely pink, eco -synophilic destruction of the vessel wall.

That smudgy pink ring is fibrinoid necrosis.

It's the absolute hallmark of type three immune complex vasculitis.

And clinically, what disease does this look like?

Systemic lupus erythematosus, or SLE, is the classic prototype.

The severe kidney damage in lupus is largely a type three reaction.

Another example is serum sickness, which acts like a systemic vasculitis because the complex is settled in blood vessels all over the body.

Okay, let's recap quickly.

Type I is allergy with IgE.

Type II is direct antibody attack on a fixed target.

Type III is circulating clumps causing fibrinoid necrosis.

That leaves type IV.

Type IV is T -cell mediated hypersensitivity.

Notice there are absolutely no antibodies involved here.

This is purely cellular.

It's also called delayed type hypersensitivity because it takes 24 to 48 hours to fully develop.

Like the tuberculin skin test, PPD.

You get the shot and the doctor tells you to come back in two days to read it.

Why the big delay?

Because it takes time for the specific memory T -cells to travel through the blood to the site of the injection in the skin,

recognize the antigen, and then secrete cytokines to recruit macrophages.

This isn't a rapid chemical explosion like histamine.

It's a coordinated troop deployment.

That takes a couple of days.

There are two flavors of type IV as well based on our T -cell types.

First, you have CD4 mediated delayed hypersensitivity.

The helper T -cells secrete cytokines like interferon gamma causing macrophage heavy inflammation.

This is the mechanism for the tuberculin test or contact dermatitis like when you brush up against poison IV.

And if that antigen can't be cleared, it changes shape, right?

Yes.

If the inflammation is chronic, like with the stubborn mycobacterium, the CD4 cells and macrophages transform.

The macrophages fuse into giant cells and form a granuloma.

It's basically a fibrous ball of immune cells trying to physically wall off the offender.

We see that classically in tuberculosis.

Right.

And the second flavor?

The second flavor is CD8 mediated.

This is direct cell -mediated cytotoxicity.

The CD8 T -cells recognize an antigen on a host cell and just directly execute it.

This is exactly what happens in type I diabetes.

The CD8 cells mistakenly recognize the insulin -producing beta cells in the pancreas as foreign and systematically destroy them.

There's a specific visual highlight in Robbins for type 5e skin reactions.

Figure 6 .9 line.

Ah, yes.

Hair vascular cuffing.

If you take a biopsy of the scan in a delayed type reaction and look under the microscope, you see lymphocytes gathering tightly around the small blood vessels, almost like a thick sleeve or a cuff.

That dense lymphocytic infiltrate is the classic sign of a T -cell invasion into the tissue.

Excellent.

Okay.

Those are the exact mechanisms of hypersensitivity injury.

Now let's talk about when the target of that injury is, well, us.

Section 3.

Autoimmune diseases.

This is the Civil War section.

Ideally, we shouldn't attack ourselves because we have something called immunologic tolerance.

Right.

Tolerance is defined as specific unresponsiveness to self -antigens.

We have to essentially train our immune cells not to attack our own biological barcode.

And this training happens in two distinct phases.

First is central tolerance.

This is the grueling boot camp in the primary lymphoid organs, the thymus and the bone marrow.

How does that boot camp actually work?

It's a rigorous test, especially for T -cells in the thymus.

There is a fascinating gene in the thymus called AIR, the autoimmune regulator gene.

AIR?

Yes, AIR allows the thymus to actually manufacture and display self -proteins from all over the body.

It shows the developing T -cells, insulin from the pancreas, thyroglobulin from the thyroid, basic myelin from the brain.

So it's basically a museum of everything in the body.

Exactly.

And if a young T -cell binds strongly to any of those self -antigens in the thymus, it immediately gets the death signal.

Apoptosis.

It fails the test and is eliminated.

We call that negative selection.

That's incredibly efficient.

It is.

But no biological system is 100 % perfect.

Some self -reactive cells inevitably slip through the cracks and escape out into the body.

And that is exactly where peripheral tolerance comes in.

The safety net.

The peripheral safety net.

Mature T -cells that go rogue out in the tissues can be silenced by a few mechanisms.

They can undergo energy, which means they are dysfunctionally paralyzed and turned off.

Or they can be suppressed by regulatory T -cells or TREGs.

TREGs are like the peacekeepers of the immune system.

They are.

They secrete inhibitory cytokines like IL -10 and TGF -beta to tell the other T -cells to chill out and stand down.

So autoimmunity is what happens when both central and peripheral tolerance completely fail.

What actually triggers that failure?

Why does someone suddenly develop an autoimmune disease?

It's always a complex mix of nature and nurture.

Genetics play a massive role.

Specifically, your HLA alleles.

HLA is the human version of those MHC display trays we talked about.

If you inherit certain specific HLA types, you are statistically much more prone to autoimmunity.

But genes aren't destiny, right?

Just having the gene doesn't guarantee the disease.

Correct.

You need an environmental trigger to set the whole thing off.

Usually, it's an infection or tissue damage.

Let's talk about molecular mimicry here.

Because this is a fascinating concept for how an infection triggers autoimmunity.

It really is elegant in a destructive way.

Imagine a microbe, say streptococcus, infects your throat.

It has a specific protein on its cell wall.

But structurally, that bacterial protein looks incredibly similar to a normal protein found in your own heart valves.

It mimics it.

So your immune system correctly builds a massive army of antibodies to kill the strep bacteria.

You clear the infection.

But those newly minted antibodies are floating around and they bump into your heart valve.

Because the protein shapes are so similar, the antibodies accidentally fit the heart valve too.

So after the strep is totally gone, your immune system turns around and viciously infects your own heart.

Exactly.

That is the exact pathogenesis of rheumatic heart disease.

The microbe mimicked the self -tissue, and the immune system got confused and broke tolerance.

Unbelievable.

Now let's dive into the specific autoimmune diseases Robin's highlights.

The absolute prototype, the big one we have to know inside and out, is systemic lupus erythematosus, SLE.

We need to spend some real time here.

We do.

SLE is known historically as the great imitator, because it can affect almost any organ system.

It is a chronic remitting and relapsing multi -system autoimmune disease caused by a massive failure of self -tolerance.

The absolute fundamental hallmark is the production of autoantibodies.

Specifically, anti -nuclear antibodies, or ANA.

Anti -nuclear.

Meaning these antibodies are attacking the actual nucleus of the cell.

Yes.

They attack DNA, they attack histones, they attack the proteins bound to RNA, they're attacking the very core instructions of your cells.

And clinically, it's incredibly variable.

Medical students often use the mnemonic STOEOP brain MD to remember the diagnostic criteria.

You've got serositis, which is inflammation of the heart or lung lining, oral ulcers, arthritis.

Right, non -erosive arthritis.

And neurologically, they can get seizures or psychosis, because antibodies can cross the blood -brain barrier.

But let's look at the tissue injury mechanisms.

We said earlier it's mostly type 3 hypersensitivity, right?

It's predominantly type 3, yes.

Those immune complexes form in the blood.

So you have a strand of your own DNA bound to an anti -DNA antibody.

It forms a clump, and those clumps deposit everywhere.

But the kidney is the most critical and often fatal site of deposition.

We call it lupus nephritis.

What does lupus nephritis look like under the microscope?

The glomeruli, the filtering units, become highly inflamed and hypercellular.

But that classic buzzword is wire loop lesions.

The capillary walls get so incredibly thick with immune complex deposits that under the microscope they look like rigid, thick wire loops.

It's a very classic severe finding.

And what about the skin manifestations?

The most famous is the butterfly rash, or malar erythema.

It's a red, raised rash that spreads across the bridge of the nose and both cheeks in the shape of a butterfly.

And importantly, it gets much, much worse with sun exposure.

That's called photosensitivity.

UV light actually causes apoptosis of skin cells, releasing more nuclear antigens, which feeds the autoimmune fire.

Wow.

And you mentioned the heart earlier, too.

Yes.

The heart in SLE has a very unique pathology called Libman -Sachs endocarditis.

You get these sterile vegetations, their little warty clumps of immune complexes, and inflammatory gunk.

And they're sterile, meaning no bacteria in them.

Right.

And uniquely, they form on both sides of the heart valves, on the top and the bottom of the leaflets.

That is a hallmark finding unique to lupus.

Okay, next major disease up is Sjogren syndrome.

This one is often paired secondarily with lupus or rheumatoid arthritis, but it can be its own primary disease.

Yes.

Sjogren is primarily a disease defined by the autoimmune destruction of the exocrine glands, specifically the lacrimal glands, which make tears, and the salivary glands, which make spit.

So the classic patient complaint is, I feel like I have sand in my eyes.

Exactly.

Dry eyes, medically called keratoconjunctivitis sicka, and severely dry mouth, called xerostomia.

They have terrible difficulty swallowing dry food like a cracker.

Their tongue gets fissured, and their teeth rapidly rot because they have no protective saliva to wash away bacteria.

If a pathologist takes a tiny biopsy of the inner lip to look at those minor salivary glands, what do they see?

You see an incredibly intense lymphocytic infiltrate physically destroying the glandular tissue.

It's mostly CD4 T cells and B cells.

In fact, the lymphoid reaction can be so dense and organized that it actually creates full -blown germinal centers right there in the salivary gland.

It can look so disorganized, it mimics lymphoma.

And there is a very scary high -yield clinical correlation there.

There absolutely is.

You have to remember this fact.

Sjogren patients have up to a 40 -fold higher risk of developing a true B -cell lymphoma compared to the normal population.

40 -fold?

That's massive.

It is.

That intense chronic B -cell hyperactivity in the glands could eventually spiral out of control, pick up a mutation, and become a malignant marginal zone lymphoma.

So if a Sjogren patient who has had shrunken glands for years suddenly develops the unilaterally enlarged hard carotid gland, you need to worry about cancer immediately.

That is critical.

Okay, the third major autoimmune condition in this Robbins chapter is systemic sclerosis, commonly called scleroderma.

Right, so the scleroderma literally translates to hard skin.

And that tells you the pathology.

This disease is characterized by relentless excessive fibrosis throughout the body.

It's not just acute inflammation.

It's a profound scarring process.

What's the cellular pathway there?

Why does the body slowly turn into stone?

It's a vicious cycle that starts in the microvasculature.

There is initial immune -mediated damage to the endothelial cells lining the small blood vessels.

This chronic vascular injury recruits macrophages and they release massive amounts of fibrogenic growth factors.

The main culprit you need to know is TGF -beta.

TGF -beta, transforming growth factor beta.

Exactly.

TGF -beta is a remarkably potent stimulator of fibroblasts.

And fibroblasts are the cells that manufacture collagen.

Right, so the fibroblasts basically go crazy, they lose their off -switch, they lay down massive amounts of dense collagen completely inappropriately everywhere in the body.

The skin becomes intensely tight, leathery, and bound down to the underlying tissue.

The fingers become tapered and stiff, almost claw -like, which is called sclerodactyly.

And it's not just a cosmetic skin issue.

It fatally affects the internal organs too, especially the GI tract.

Esophageal fibrosis is a classic internal manifestation.

The normally flexible muscular lower esophagus gets replaced by rigid collagen.

It literally turns into a stiff rubber pipe.

Patients have terrible difficulty swallowing dysphagia and severe acid reflux.

It can also heavily scar the lungs, causing restrictive lung disease, and scar the kidneys, causing malignant hypertension.

Brutal disease.

So we've exhaustively covered the body attacking itself.

Now let's completely flip the script.

What happens when medical science tries to put someone else's tissue into a patient's body?

Let's move to section 4, rejection of transplants.

The non -self problem.

When you surgically place a graft, like a donor kidney, into a patient, the recipient's immune system immediately patrols it.

It checks those MHC molecules we talked about earlier.

And unless the donor is an identical twin, the MHC molecules will not match perfectly.

The recipient's T cells see those foreign MHC trays and initiate an attack.

I really want to clarify how the T cell actually realizes the kidney is foreign.

Because Robbins details two different pathways for this a la recognition.

The direct and the indirect pathway.

And this always confuses people.

It is a major mental hurdle for students.

Okay, let's break it down.

Imagine the donor kidney is transplanted.

Sitting inside that kidney tissue are some of the donor's own dendritic cells.

They were just hanging out in the tissue, and they came along for the ride during the surgery.

We call them passenger leukocytes.

Okay, so the donor's immune skeletal are literally still inside the transplanted kidney.

Right.

Now, those donor dendritic cells crawl out of the kidney draft, travel through the lymphatics to the recipient's lymph node, and present themselves to the recipient's T cells.

So the recipient's T cell is looking directly at a completely foreign MHC molecule on a completely foreign cell.

Oh wow, so the T cell just sees this bizarre alien structure?

Yes.

That is the direct pathway.

It acts almost like a superantigen.

It cross -reacts wildly with the recipient's T cell receptors and provokes a massive, immediate, violent CD8 cytotoxic response.

The direct pathway is the main driver of acute cellular rejection.

Okay, that makes sense.

Direct, foreign APC, foreign MHC, and the indirect pathway.

The indirect pathway is much more like a standard infection response.

The recipient's own dendritic cells enter the new kidney graft, scavenge around, pick up pieces of dead donor cells, process those foreign donor proteins, and present them on the recipient's self -MHC molecules back in the lymph node.

So the recipient's T cell looks at its own familiar dendritic cell, but it's holding up a weird foreign kidney protein.

Exactly.

The T cell says, look at this strange protein I found.

This indirect presentation usually drives a CD4 helper T cell response, which promotes inflammation and, crucially, helps B cells make antibodies against the graft.

This pathway is heavily involved in chronic rejection.

Brilliant breakdown.

Now, the text neatly categorizes the actual clinical rejection patterns by their timeline, which is super helpful for diagnosis on the wards.

Let's run through them.

Hyperacute, acute, and chronic.

Hyperacute rejection is dramatic.

It happens in minutes to hours.

This is a surgical nightmare scenario.

It happens because the recipient already has preformed antibodies circulating in their blood against the donor -specific blood type or HLA antigens, maybe from a previous failed transplant, prior pregnancy, or a blood transfusion.

So the surgeon stitches the vessels together, unclamps the blood flow, and what happens?

The organ turns bruised and blue almost immediately.

It becomes cyanotic right there on the table.

Those preformed antibodies instantly bind to the endothelial cells of the graft's blood vessels.

They trigger the complement cascade, cause massive thrombosis, and completely occlude the vessels.

The graft dies from ischemia before the patient even leaves the operating room.

Wow.

Do we see that often?

Thankfully, we essentially don't see this anymore in modern medicine, because we cross -match the donor and recipient blood so rigorously beforehand.

Good.

Then there's acute rejection.

This takes days to weeks to develop.

The patient initially does fine, but then kidney function starts dropping.

This is usually the T -cells finally waking up, proliferating, and attacking the tissue.

That's cellular rejection.

Under the microscope, you see dense lymphocytes invading the kidney tubules, which is called tubulitis.

Or it can be cumeral, meaning new antibodies are forming and causing vasculitis.

Like this one we can treat, right?

Acute rejection is usually highly responsive to bumping up the patient's immunosuppressive drugs.

We can reverse it.

And finally, chronic rejection.

This happens months to years, sometimes decades later.

It is an insidious slow failure of the organ.

Pathologically, it is dominated by arteriosclerosis.

The hardening and narrowing of the graft's blood vessels.

Chronic low -grade inflammation driven by that indirect pathway in cytokines causes the smooth muscle cells in the vessel walls to drastically proliferate.

The vessel lumen gets narrower and narrower.

The organ slowly starves of oxygen, leading to widespread interstitial fibrosis and atrophy of the kidney tubules.

And, unfortunately, you can't really reverse scarring.

Exactly.

It's incredibly hard to treat because it's a structural scarring process, not just active reversible inflammation.

Before we completely leave transplants, we absolutely have to mention the reverse scenario, which is graft versus host disease or GVHD.

This is a fascinating and profoundly tragic pathology.

Primarily happens in bone marrow or hematopoietic stem cell transplants.

Think about what you're doing.

You are destroying the patient's diseased immune system with radiation, and you are literally giving them a brand new functional immune system from a donor.

So the graft is the immune system itself.

Exactly.

So if that new immune system, the graft, wakes up, looks around, and sees the patient's entire body, the host, as foreign, it violently attacks.

So the transplant attacks the patient.

That's terrifying.

It is.

The donor's immunocompetent T cells systematically attack the recipient's tissues.

And GVHD has three highly specific clinical targets you need to remember.

The skin, causing a generalized rash and severe desquamation.

The liver, causing destruction of bile ducts and severe jaundice.

And the gut, causing mucosal ulceration and massive bloody diarrhea.

It is a systemic devastating attack from within.

All right.

We've talked extensively about the immune system doing too much.

Hypersensitivity, autoimmunity, rejection.

Now let's pivot to section five.

What happens when the system just completely fails?

Immunodeficiency diseases.

System failure.

We broadly divide these into primary, which means genetic or inborn errors you were born with, and secondary, which are acquired later in life.

The primary ones are rare, but they are highly tested because they elegantly prove exactly how the system is supposed to work by showing us what happens when one specific piece is missing.

Right.

It's like pulling a single spark plug out of an engine to see what it does.

Let's look at the defects in innate immunity first.

Fagacite defects.

You have conditions like leukocyte adhesion deficiency or LED.

The neutrophils are perfectly healthy.

They can kill bugs fine, but they genetically lack the adhesion molecules, the integrins on their surface.

So they literally can't stick to the blood vessel wall to exit the bloodstream and get out to the tissue infection.

They're just trapped in the traffic of the blood, driving right past the burning building.

Exactly.

So clinically, you see massive infections with absolutely no pus formation because pus is just dead neutrophils and they can't get there.

Also, a classic sign is the umbilical cord fails to separate in the newborn because you need neutrophils to come in and digest that tissue to make it fall off.

Fascinating.

And what about chronic granulomatous disease, CGD?

In CGD, the neutrophils can get to the tissue and they can physically eat the microbes, but they can't kill them.

They have a genetic defect in an enzyme called phagocyte oxidase.

This is the enzyme that makes superoxide the respiratory burst.

It's the bleach they use to kill the bacteria.

So they eat the bacteria, but it just lives inside them.

Yes.

So the immune system panics and calls in more macrophages and they just wall off the area forming massive granulomas everywhere.

Hence the name.

Okay, then we have defects in adaptive immunity.

These are the lymphocyte defects.

Let's rapid fire the key syndromes Robin's highlights.

First, X -linked agammaglobulinemia or Brutin disease.

Brutin equals no B cells.

It is a genetic defect in a specific signaling protein called Brutin tyrosine kinase or BTK.

This kinase is absolutely required for B cells to mature in the bone marrow.

Without it, they get stuck as pre -B cells.

So no mature B cells means no antibodies.

None.

Pan hypergammaglobulinemia.

And because it's X -linked, it almost exclusively affects infant boys.

But here's the trick.

They don't get sick right away.

They present with severe recurrent bacterial infections only after about six months of age.

Why the delay?

Because for the first six months, they are protected by their mother's IgG antibodies that cross the placenta.

Once mom's antibodies fade away, the defect is unmasked.

Got it.

Next is common variable immunodeficiency, CVID.

How is this different from Brutin?

In CVV'd, they actually have normal numbers of B cells circulating in the blood.

But those B cells are defective.

They get triggered.

But they fail to undergo final differentiation into antibody -secreting plasma cells.

So the B cells are there.

They're just lazy.

Essentially, yes.

So they still have very low antibody levels, but the B cell count is normal.

Clinically, these patients often have massive hyperplasia of their lymph nodes and spleen because the B cells are accumulating, trying to work, getting stimulated, but they just can't finish the job.

Okay.

Isolated IgA deficiency.

Yeah, this is actually the most common primary immunodeficiency.

They have normal IgG and IgM, but critically low IgA.

Since IgA is the primary antibody guarding eucosal surfaces, these patients suffer from recurrent sinus infections, respiratory tract infections, and chronic diarrhea.

This is a very classic association with Giardia infections in the gut.

HyperIgM syndrome.

The name tells you what's high, but what's broken.

This is a tricky one.

It presents as an antibody problem, but it's actually a T cell defect.

The CD4 helper T cells have a mutation in a surface protein called CD40 ligand.

And CD40 ligand is what the T cell uses to physically handshake with the B cell?

Precisely.

Without that physical handshake, the B cell doesn't get the signal to undergo class switching.

So the B cells just keep pumping out the default early antibody, which is IgM.

They can never switch to make IgG, IgA, or IgE.

So you get huge elevated levels of IgM, but zero of the specialized antibodies leading to terrible pyogenic infections.

Okay, moving strictly to T cell defects.

DeGeorge syndrome.

DeGeorge is a developmental failure of the third and fourth pharyngeal pouches during embryogenesis.

Those pouches are supposed to form the thymus and the parathyroid glands.

So no thymus means absolutely no T cells.

Right.

These kids have profound T cell deficiency, making them highly susceptible to fatal viral and fungal infections.

And because they also lack parathyroid glands, they can't regulate calcium.

They often present in the newborn nursery with severe tetanine seizures due to extreme hypocalcemia.

And the most severe primary deficiency of all, SCID,

severe combined immunodeficiency.

The famous bubble boy disease.

This is a complete failure of both the T cell and the B cell compartments.

The adaptive immune system is simply non -existent.

What causes that level of failure?

There are two major genetic causes Robbins wants you to know.

First is an X -link mutation in the common gamma chain of cytokine receptors.

Without that receptor subunit, lymphocytes can't receive any growth signals, so they never develop.

And the second cause.

An autosomal recessive defect in an enzyme called adenosine deminase, or ADA.

Without ADA,

extremely toxic metabolic byproducts rapidly build up inside the lymphocytes and literally poison them to death.

Either way, without an immediate bone marrow transplant, these children have zero defense and cannot survive beyond infancy out in the world.

Wow.

And finally, for the primary ones, Whiscott -Aldrich syndrome.

Remember the classic clinical triad for Whiscott -Aldrich?

It's X -linked.

The triad is eczema, severe thrombocytopenia, which means low platelets causing bleeding, and immunodeficiency.

It's caused by a defect in a protein that links membrane receptors to the cytoskeleton.

So the immune cells physically can't rearrange their internal skeleton to move, crawl, or interact with other cells correctly.

Okay.

The text also briefly touches on secondary immunodeficiencies, mainly noting that things like disseminated cancer, severe malnutrition, or iatrogenic causes like chemotherapy can wipe out the immune system.

Right.

And of course, AIDS.

AIDS is the most globally devastating example of secondary immunodeficiency caused by the HIV virus, specifically infecting and actively destroying those CD4 -helper T cells.

The generals.

Exactly.

When the generals are dead, the entire adaptive immune response collapses.

The text actually defers the deep molecular dive on HIV to a later chapter on infectious disease.

But strictly speaking, in our context, it is the ultimate catastrophic example of acquired T cell failure.

All right.

We are in the homestretch.

We have one final section.

It's unique because it's usually grouped with these immune diseases, but pathologically, it's really a protein folding problem.

Section six, amyloidosis.

Amyloidosis.

This is a great topic.

It is not a single distinct disease.

It's a broad condition where various abnormal proteins structurally misfold.

They lose their normal 3D shape and fold into what we call beta pleated sheets.

Beta pleated sheets.

I always hear that and it sounds like a nice betting set.

I wish.

Pathologically, that specific physical structure makes the protein completely insoluble and highly resistant to normal enzymatic digestion.

The body's cleanup crews, the macrophages literally cannot break it down.

So what happens to it?

Does it just float around?

No.

These rigid sheets deposit extracellularly outside the cells in the connective tissues of various organs, and they just pile up layer by layer.

So they physically squeeze the healthy cells to death.

That's exactly it.

It causes massive pressure atrophy.

They clog up the extracellular space, stiffen the organ, and slowly choke out the functional cells.

Okay.

There is one sentence, one specific phrase that every single medical student absolutely knows by heart for amyloidosis.

Oh, yes.

The Congo red stain.

If a pathologist suspects amyloid, they stain the biossy tissue with a special dye called Congo red.

Under normal light, the amyloid looks pink or red.

But when you put that slide under polarized light, the amyloid deposits glow with a brilliant apple green birefringence.

Apple green and birefringence.

Yes.

If you ever see those words on a board question or in a pathology report, stop reading.

The answer is amyloidosis.

It is highly specific.

So what are these misfolded proteins actually made of?

Where do they come from?

Robbins focuses on the two most common systemic types you need to know.

First is AL amyloid.

AL stands for amyloid light chain.

This type comes directly from plasma cell tumors like multiple myeloma.

The malignant plasma cells pump out massive excessive amounts of antibody light chains.

These excess chains misfold, form beta sheets, and deposit as AL amyloid.

So AL is essentially an immune system cancer byproduct.

What about the second type?

The second is AA amyloid.

AA stands for amyloid associated.

This type is driven by chronic, long -standing systemic inflammation.

Conditions like severe rheumatoid arthritis,

chronic osteomyelitis, or inflammatory bowel disease.

How does inflammation cause amyloid?

When the body is constantly inflamed, macrophages constantly secrete IL -1 and IL -6.

These cytokines tell the liver to continuously pump out an acute phase reactive protein called SAA,

serum amyloid associated protein.

Over years, that massive excess of SAA gets partially degraded, misfolds, and deposits in the tissues as AA amyloid.

Okay, so morphologically, where do these amyloid proteins go?

What organs do they ruin?

Systemic amyloid can deposit practically anywhere, but the kidney is the most common and often the most serious organ involved.

The rigid amyloid deposits heavily in the glomeruli.

It completely destroys the filtering mechanism, leading to massive protein leakage into the nephrotic syndrome, and eventually complete renal failure.

And the heart.

We talked about the heart earlier.

Cardiac amyloidosis is classic.

The protein deposits between the myocardial muscle fibers.

The heart becomes incredibly stiff and rubbery, almost like a dense stress ball.

It can squeeze fine, but it can't relax to fill with blood.

We call that restrictive cardiomyopathy, and it causes severe intractable heart failure.

It can even deposit in the tongue, right?

Yes.

Macroglossia.

The amyloid deposits physically enlarge the tongue until it is visibly massive, firm, and protruding.

That's a classic high -yield physical exam finding.

It can also deposit in the wrist ligaments, compressing the median nerve and causing severe carfel tunnel syndrome, which is especially common in patients on long -term dialysis.

Wow.

From the incredible microscopic elegance of a lymph node to the absolute tragedy of a bubble boy, and finally the striking apple green shine of amyloid protein,

we have actually covered the Robin's Chapter.

It is an immense dense landscape of pathology.

We've gone from the tiny molecular level of NFKB signaling all the way up to complex systemic multi -organ diseases like lupus and scleroderma.

So, as we wrap up this deep dive, let's try to synthesize all of this.

For the student listening, what does this all mean in the grand scheme?

For me, the ultimate takeaway from this chapter is the profound concept of balance.

Pathology in the immune system isn't just about weakness or immunodeficiency.

The vast majority of the tissue damage and the terrible diseases we discuss today, hypersensitivity, autoimmunity, transplant rejection, they all come from the system having way too much strength or completely misdirected strength.

Right.

It's a delicate ongoing negotiation.

Exactly.

It's a constant microscopic negotiation between self and non -self.

The system has to be aggressive and violent enough to instantly kill or replicating virus, but restrained and disciplined enough not to melt down your own kidneys in the process.

When that precise balance tips, even slightly, you get devastating disease.

And that is a really provocative thought to leave you all with.

We constantly hear in pop culture and advertising that we need to boost our immune systems.

We buy supplements and teas to boost immunity.

But when you actually sit down and look at the deep pathology, you realize that a boosted immune system, one that is highly hyperreactive, is actually the exact cause of debilitating allergies and autoimmune diseases.

Right.

Maybe what we really want isn't a remarkably strong immune system, but a highly smart one.

A heavily disciplined one.

Exactly.

Well, thank you for joining us for this intense deep dive into the pathologic basis of disease.

We hope this helped connect the dots for you.

It was a true pleasure walking through it.

A warm thank you from the Last Minute Lecture Team.

Good luck on your exams and we will see you in the next chapter.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
The text thoroughly outlines the cellular and molecular components of the innate immune response, including epithelial barriers, phagocytes, natural killer cells, and pattern recognition receptors (such as Toll-like and NOD-like receptors), alongside the highly specific adaptive immune response governed by T and B lymphocytes, antigen-presenting cells, and the major histocompatibility complex (MHC). Building upon these fundamental concepts, the chapter systematically categorizes immunologically mediated tissue injury into four distinct hypersensitivity reactions: immediate, IgE-mediated responses (Type I) typical of allergies and anaphylaxis; antibody-mediated cellular dysfunction and destruction (Type II); immune complex-mediated inflammation (Type III) seen in conditions like serum sickness; and T cell-mediated cellular cytotoxicity and delayed-type hypersensitivity (Type IV). A profound emphasis is placed on the breakdown of central and peripheral immunologic tolerance, which paves the way for autoimmune diseases. The etiology and morphological hallmarks of prominent systemic autoimmune conditions are detailed, notably Systemic Lupus Erythematosus (SLE), driven by antinuclear antibodies and immune complex deposition; Sjögren syndrome, characterized by immune-mediated destruction of exocrine glands; and Systemic Sclerosis (scleroderma), marked by progressive tissue fibrosis and microvascular damage. Furthermore, the chapter delves into the immunological mechanisms underlying tissue transplant rejection, differentiating between hyperacute, acute, and chronic rejection pathways, as well as graft-versus-host disease (GVHD). The spectrum of immunodeficiency diseases is heavily analyzed, distinguishing between congenital, primary defects in immune cell maturation or activation—such as Severe Combined Immunodeficiency (SCID), X-linked agammaglobulinemia, and DiGeorge syndrome—and secondary, acquired immune failures. Chief among the latter is a rigorous clinical and pathological review of HIV infection and AIDS, detailing the viral pathogenesis, CD4+ helper T-cell depletion, and the resulting susceptibility to opportunistic infections and neoplasms like Kaposi sarcoma. Finally, the chapter concludes with a detailed examination of amyloidosis, explaining how the extracellular deposition of abnormal, misfolded fibrillary proteins—whether amyloid light chain (AL), amyloid-associated (AA), or variant transthyretin (ATTR)—leads to insidious and progressive multi-organ dysfunction that is classically identified through Congo red staining and apple-green birefringence.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥